Gene · 2633
Papers1,970
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,970
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovering common pathogenetic processes between COVID-19 and tuberculosis by bioinformatics and system biology approach. | Front Cell Infect Microbiol | 2023 | 38162574 | PubTator, text mining | PubMed |
| A Case of Multi-Organ Tuberculosis Misdiagnosed as Lung Cancer and a Literature Review. | Cancer Manag Res | 2023 | 38161787 | PubTator, text mining | PubMed |
| Computational Characterization of Undifferentially Expressed Genes with Altered Transcription Regulation in Lung Cancer. | Genes (Basel) | 2023 | 38136991 | PubTator, text mining | PubMed |
| Biological analysis of the potential pathogenic mechanisms of Infectious COVID-19 and Guillain-Barré syndrome. | Front Immunol | 2023 | 38115996 | PubTator, text mining | PubMed |
| Exploration of the biomarkers of comorbidity of psoriasis with inflammatory bowel disease and their association with immune infiltration. | Skin Res Technol | 2023 | 38115636 | PubTator, text mining | PubMed |
| The two-stage molecular scenery of SARS-CoV-2 infection with implications to disease severity: An in-silico quest. | Front Immunol | 2023 | 38077337 | PubTator, text mining | PubMed |
| Identification of drug candidates targeting monocyte reprogramming in people living with HIV. | Front Immunol | 2023 | 38077315 | PubTator, text mining | PubMed |
| Identification of Key Genes for Pyroptosis-Induced Salivary Gland Inflammation in Sjogren's Syndrome Based on Microarray Data and Immunohistochemistry Analysis. | J Inflamm Res | 2023 | 38076335 | PubTator, text mining | PubMed |
| Construction and analysis of pseudogene-related ceRNA network in breast cancer. | Sci Rep | 2023 | 38072995 | PubTator, text mining | PubMed |
| Inflammation and Immunity Gene Expression Patterns and Machine Learning Approaches in Association with Response to Immune-Checkpoint Inhibitors-Based Treatments in Clear-Cell Renal Carcinoma. | Cancers (Basel) | 2023 | 38067341 | PubTator, text mining | PubMed |
| Comprehensive Transcriptome Analysis Reveals the Distinct Gene Expression Patterns of Tumor Microenvironment in HPV-Associated and HPV-Non Associated Tonsillar Squamous Cell Carcinoma. | Cancers (Basel) | 2023 | 38067251 | PubTator, text mining | PubMed |
| Tumour cells can escape antiproliferative pressure by interferon-β through immunoediting of interferon receptor expression. | Cancer Cell Int | 2023 | 38066598 | PubTator, text mining | PubMed |
| Identification of interferon-stimulated genes with modulated expression during hepatitis E virus infection in pig liver tissues and human HepaRG cells. | Front Immunol | 2023 | 38058490 | PubTator, text mining | PubMed |
| Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial. | Cell Rep Med | 2023 | 38056464 | PubTator, text mining | PubMed |
| Urinary single-cell sequence analysis of the urinary macrophage in different outcomes of membranous nephropathy. | Clin Kidney J | 2023 | 38046013 | PubTator, text mining | PubMed |
| Biomarkers and experimental models for cancer immunology investigation. | MedComm (2020) | 2023 | 38045830 | PubTator, text mining | PubMed |
| PIM kinases regulate early human Th17 cell differentiation. | Cell Rep | 2023 | 38039135 | PubTator, text mining | PubMed |
| The effect of TLR3 priming conditions on MSC immunosuppressive properties. | Stem Cell Res Ther | 2023 | 38031182 | PubTator, text mining | PubMed |
| PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma. | Nat Commun | 2023 | 38030622 | PubTator, text mining | PubMed |
| Guanylate-binding protein 1 modulates proteasomal machinery in ovarian cancer. | iScience | 2023 | 38026225 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2633/papers?page=9